No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Abraxane is a chemotherapy drug used to treat non-small cell lung cancer (NSCLC). It is a nanoparticle albumin-bound (nab) paclitaxel, a type of chemotherapy drug that is delivered directly to the tumor cells. Abraxane is used in combination with other drugs to treat NSCLC, and is often used in combination with carboplatin or cisplatin. Abraxane has been shown to be more effective than traditional paclitaxel in treating NSCLC, and has fewer side effects. Abraxane is also used to treat other types of cancer, including breast, ovarian, and pancreatic cancer.
The Abraxane market is highly competitive, with several companies offering similar products. Some of the major players in the market include Celgene Corporation, Bristol-Myers Squibb, Pfizer, and Merck & Co. Other companies in the market include AstraZeneca, Novartis, and Eli Lilly. Show Less Read more
